Drawing for APPLIFLEX

USPTO serial 79017627

APPLIFLEX

Reviewed by CopyMark Law Group

Reg. 3220273Status 404
Filing date
Status date
Registration date
Mar 20, 2007
Examiner
MORRIS, KRISTINA KLOIBER
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with APPLIFLEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

William J. Seiter

William J. Seiter Seiter Legal Studio2500 Broadway, Bldg F, Suite F-125Santa Monica, CA 90404UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Bioreactors, namely reactors for growing bacteria, animal cells and plant cells for the production of biological products in the nature of vaccines, therapeutic and diagnostic preparations and proteins, and component parts thereofSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 19, 2018DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Apr 19, 2018DETHDEATH OF INTERNATIONAL REGISTRATION—
Mar 16, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 26, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 20, 2016REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Apr 3, 2013NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Apr 3, 2013C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Apr 3, 2013715FREGISTERED - SEC. 71 & SEC. 15 FILED—
Apr 3, 2013APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 19, 2013ES75TEAS SECTION 71 & 15 RECEIVED—
Mar 17, 2013NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 16, 2009ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jun 27, 2008FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 18, 2007FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 18, 2007FIMPFINAL DISPOSITION PROCESSED—
Sep 17, 2007FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 21, 2007CHLDCHANGE OF OWNER RECEIVED FROM IB—
Mar 20, 2007R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 2, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 13, 2006NPUBNOTICE OF PUBLICATION—
Nov 9, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 3, 2006ALIEASSIGNED TO LIE—
Oct 30, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 24, 2006ACECAMENDMENT FROM APPLICANT ENTERED—
Sep 12, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 12, 2006FAXXFAX RECEIVED—
Apr 27, 2006RFNTREFUSAL PROCESSED BY IB—
Apr 7, 2006RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 7, 2006RFRRREFUSAL PROCESSED BY MPU—
Apr 5, 2006RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 4, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 22, 2006DOCKASSIGNED TO EXAMINER—
Dec 9, 2005NWAPNEW APPLICATION ENTERED—
Dec 8, 2005REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance